SG11202104384PA - Substituted oxopyridine derivatives - Google Patents
Substituted oxopyridine derivativesInfo
- Publication number
- SG11202104384PA SG11202104384PA SG11202104384PA SG11202104384PA SG11202104384PA SG 11202104384P A SG11202104384P A SG 11202104384PA SG 11202104384P A SG11202104384P A SG 11202104384PA SG 11202104384P A SG11202104384P A SG 11202104384PA SG 11202104384P A SG11202104384P A SG 11202104384PA
- Authority
- SG
- Singapore
- Prior art keywords
- oxopyridine derivatives
- substituted oxopyridine
- substituted
- derivatives
- oxopyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018122825 | 2018-12-21 | ||
| PCT/EP2019/085983 WO2020127504A1 (en) | 2018-12-21 | 2019-12-18 | Substituted oxopyridine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202104384PA true SG11202104384PA (en) | 2021-05-28 |
Family
ID=69143542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202104384PA SG11202104384PA (en) | 2018-12-21 | 2019-12-18 | Substituted oxopyridine derivatives |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP3898633A1 (en) |
| JP (1) | JP2022514303A (en) |
| KR (1) | KR20210106504A (en) |
| CN (1) | CN113474348A (en) |
| AR (1) | AR117435A1 (en) |
| AU (1) | AU2019407909B2 (en) |
| BR (1) | BR112021009435A2 (en) |
| CA (1) | CA3124220A1 (en) |
| CL (1) | CL2021001613A1 (en) |
| CO (1) | CO2021007908A2 (en) |
| CR (1) | CR20210342A (en) |
| DO (1) | DOP2021000128A (en) |
| EA (1) | EA202191764A1 (en) |
| EC (1) | ECSP21043895A (en) |
| IL (1) | IL283990A (en) |
| JO (1) | JOP20210161A1 (en) |
| MA (1) | MA54521A (en) |
| MX (1) | MX2021007508A (en) |
| PE (1) | PE20211790A1 (en) |
| SG (1) | SG11202104384PA (en) |
| TW (1) | TW202039510A (en) |
| WO (1) | WO2020127504A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111770917B (en) * | 2018-03-15 | 2023-09-26 | 拜耳股份公司 | Process for the preparation of two compounds |
| CN114105881B (en) | 2020-08-31 | 2024-01-26 | 沈阳海诺威医药科技有限公司 | Platelet aggregation inhibitor, and preparation method and application thereof |
| MX2023010629A (en) | 2021-03-09 | 2023-09-19 | Bayer Ag | Pharmaceutical dosage forms com. |
| BR112023016298A2 (en) | 2021-03-09 | 2023-10-03 | Bayer Ag | CRYSTALLINE FORMS OF (4S)-24-CHLORO-4-ETHYL-73-FLUORO-35-METHOXY-32,5-DIOXO-14-(TRIFLUORO-METHYL)-32H-6-AZA-3(4,1)- PYRIDINE-1(1)-[1,2,3]TRIAZOLA-2(1,2),7(1)-DIBENZENE-HEPTAPHAN-74-CARBOXAMIDE |
| WO2022189280A1 (en) | 2021-03-09 | 2022-09-15 | Bayer Aktiengesellschaft | Solvates of (4s)-24-chloro-4-ethyl-73-fluoro-35-methoxy-32,5-dioxo-14-(trifluoro-methyl)-32 h-6- aza-3(4,1)-pyridina-1(1)-[1,2,3]triazola-2(1,2),7(1)-dibenzenaheptaphane-74-carboxamide |
| CN114560754A (en) * | 2022-02-25 | 2022-05-31 | 滁州学院 | Preparation method of alkyl alcohol |
| CN116874469B (en) * | 2023-09-06 | 2023-11-10 | 成都施贝康生物医药科技有限公司 | Oxo-pyridine compound, intermediate, preparation method and application thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0420722D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| DE102006032824A1 (en) * | 2006-07-14 | 2008-01-17 | Bayer Healthcare Ag | Substituted indazoles |
| EP2091947A2 (en) | 2006-12-20 | 2009-08-26 | Takeda San Diego, Inc. | Glucokinase activators |
| WO2014160592A2 (en) | 2013-03-27 | 2014-10-02 | Merck Sharp & Dohme Corp. | FACTOR XIa INHIBITORS |
| TWI633089B (en) * | 2013-03-28 | 2018-08-21 | 拜耳製藥股份有限公司 | Substituted oxopyridine derivatives |
| EP3024822B1 (en) | 2013-07-23 | 2017-05-03 | Bayer Pharma Aktiengesellschaft | Substituted oxopyridine derivatives and their use as factor xia and plasma kallikrein inhibitors |
| JP6368367B2 (en) | 2013-10-30 | 2018-08-01 | バイエル ファーマ アクチエンゲゼルシャフト | Substituted oxopyridine derivatives |
| ES2722423T3 (en) * | 2014-09-24 | 2019-08-12 | Bayer Pharma AG | Substituted oxopyridine derivatives |
| ES2712886T3 (en) * | 2014-09-24 | 2019-05-16 | Bayer Pharma AG | Derivatives of pyridobenzazepine and pyridobenzazocine that inhibit factor XIa |
| ES2713624T3 (en) | 2014-09-24 | 2019-05-23 | Bayer Pharma AG | Substituted oxopyridine derivatives |
| EP3197872B1 (en) | 2014-09-24 | 2019-01-30 | Bayer Pharma Aktiengesellschaft | (2h)-2-oxopyridines as faktor xia-inhibitors for treating thrombotic diseases |
| ES2694189T3 (en) | 2014-09-24 | 2018-12-18 | Bayer Pharma Aktiengesellschaft | Substituted oxopyridine derivatives |
| EP3197880B1 (en) | 2014-09-24 | 2018-10-24 | Bayer Pharma Aktiengesellschaft | Substituted oxopyridine derivatives with anti-inflammatory and anti-thrombotic effect |
| CN107428689A (en) * | 2015-03-19 | 2017-12-01 | 拜耳制药股份公司 | As the oxo pyridine derivative for treating thrombotic factor XI, plasma thromboplastin antecedent A inhibitor |
| JO3703B1 (en) | 2015-07-09 | 2021-01-31 | Bayer Pharma AG | Substituted oxopyridine derivatives |
| WO2017037051A1 (en) | 2015-09-04 | 2017-03-09 | Bayer Pharma Aktiengesellschaft | Substituted oxopyridine derivatives |
-
2019
- 2019-12-18 WO PCT/EP2019/085983 patent/WO2020127504A1/en unknown
- 2019-12-18 CA CA3124220A patent/CA3124220A1/en active Pending
- 2019-12-18 PE PE2021000903A patent/PE20211790A1/en unknown
- 2019-12-18 JO JOP/2021/0161A patent/JOP20210161A1/en unknown
- 2019-12-18 MX MX2021007508A patent/MX2021007508A/en unknown
- 2019-12-18 AU AU2019407909A patent/AU2019407909B2/en not_active Ceased
- 2019-12-18 SG SG11202104384PA patent/SG11202104384PA/en unknown
- 2019-12-18 AR ARP190103745A patent/AR117435A1/en unknown
- 2019-12-18 MA MA054521A patent/MA54521A/en unknown
- 2019-12-18 JP JP2021535063A patent/JP2022514303A/en active Pending
- 2019-12-18 EA EA202191764A patent/EA202191764A1/en unknown
- 2019-12-18 CR CR20210342A patent/CR20210342A/en unknown
- 2019-12-18 KR KR1020217022510A patent/KR20210106504A/en active Search and Examination
- 2019-12-18 CN CN201980091518.1A patent/CN113474348A/en active Pending
- 2019-12-18 EP EP19832641.5A patent/EP3898633A1/en active Pending
- 2019-12-18 TW TW108146372A patent/TW202039510A/en unknown
- 2019-12-18 BR BR112021009435-0A patent/BR112021009435A2/en not_active Application Discontinuation
-
2021
- 2021-06-14 IL IL283990A patent/IL283990A/en unknown
- 2021-06-16 EC ECSENADI202143895A patent/ECSP21043895A/en unknown
- 2021-06-16 CO CONC2021/0007908A patent/CO2021007908A2/en unknown
- 2021-06-17 CL CL2021001613A patent/CL2021001613A1/en unknown
- 2021-06-18 DO DO2021000128A patent/DOP2021000128A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019407909B2 (en) | 2023-05-25 |
| CO2021007908A2 (en) | 2021-07-19 |
| IL283990A (en) | 2021-07-29 |
| DOP2021000128A (en) | 2021-09-30 |
| TW202039510A (en) | 2020-11-01 |
| KR20210106504A (en) | 2021-08-30 |
| EA202191764A1 (en) | 2021-10-22 |
| ECSP21043895A (en) | 2021-07-30 |
| CR20210342A (en) | 2021-08-09 |
| PE20211790A1 (en) | 2021-09-09 |
| JOP20210161A1 (en) | 2023-01-30 |
| CA3124220A1 (en) | 2020-06-25 |
| MA54521A (en) | 2022-03-30 |
| AU2019407909A1 (en) | 2021-05-27 |
| BR112021009435A2 (en) | 2021-08-17 |
| CL2021001613A1 (en) | 2021-12-03 |
| JP2022514303A (en) | 2022-02-10 |
| AR117435A1 (en) | 2021-08-04 |
| WO2020127504A1 (en) | 2020-06-25 |
| EP3898633A1 (en) | 2021-10-27 |
| CN113474348A (en) | 2021-10-01 |
| MX2021007508A (en) | 2021-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3810587T (en) | Substituted alkoxypyridinyl indolsulfonamides | |
| CA185383S (en) | Casque | |
| IL271607B1 (en) | New azaquinoline derivatives | |
| CA185382S (en) | Casque | |
| CA185384S (en) | Casque | |
| IL283197A (en) | Microbiocidal 2-acylamino-thiazole-4-carboxamide derivatives | |
| CA185385S (en) | Casque | |
| IL283990A (en) | Substituted oxopyridine derivatives | |
| ZA202204675B (en) | New methylquinazolinone derivatives | |
| IL289197A (en) | 2-hydroxycycloalkane-1-carbamoyl derivatives | |
| CA184989S (en) | Uroflowmeter | |
| IL279938A (en) | Spirochromane derivatives | |
| CA184992S (en) | Uroflowmeter | |
| IL290815A (en) | Alpha-d-galactopyranoside derivatives | |
| LT3796975T (en) | Sulfonylaminobenzamide derivatives | |
| IL271290A (en) | Dihydro-pyrrolo-pyridine derivatives | |
| PL3770162T3 (en) | Dihydrochromene derivatives | |
| SG11202006837XA (en) | Dihydroindolizinone derivative | |
| GB201803155D0 (en) | Spedball | |
| GB201806948D0 (en) | Derivatives | |
| GB201919210D0 (en) | Dihydro-cyclopenta-isoquinoline derivatives | |
| AU201817248S (en) | MC-Roller | |
| AU201817245S (en) | MC-Roller | |
| PT3319956T (en) | Substituted oxopyridine derivatives |